title: Ticagrelor therapy in patients with advanced conduction disease: Is it really safe?
authors.affiliation: Interventional Cardiology Unit, Ziv Medical Center, Zfat, Israel; Faculty of Medicine in Galilee, Bar-Ilan University, Zfat, Israel. Electronic address: Alex.g@ziv.health.gov.il.
authors.forename: Alexander
authors.initials: A
authors.lastname: Goldberg
authors.affiliation: Department of Cardiology, Ziv Medical Center, Zfat, Israel.
authors.forename: Inna
authors.initials: I
authors.lastname: Rosenfeld
authors.affiliation: Department of Cardiology, Ziv Medical Center, Zfat, Israel.
authors.forename: Irena
authors.initials: I
authors.lastname: Nordkin
authors.affiliation: Faculty of Medicine in Galilee, Bar-Ilan University, Zfat, Israel; Department of Cardiology, Ziv Medical Center, Zfat, Israel.
authors.forename: Majdi
authors.initials: M
authors.lastname: Halabi
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives*; D054537:Atrioventricular Block / Q000139:chemically induced*; D002304:Cardiac Pacing, Artificial / Q000379:methods*; D004562:Electrocardiography / Q000187:drug effects*; D006801:Humans; D008297:Male
chemical_list: D000241:Adenosine